Arcturus Therapeutics Announces Third Quarter 2023 Financial Update and Pipeline Progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures subdued as investors weigh earnings, oil prices
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Arcturus Therapeutics (ARCT) Tops Q3 EPS by $1.01
November 14, 2023 4:02 PM ESTArcturus Therapeutics (NASDAQ: ARCT) reported Q3 EPS of ($0.61), $1.01 better than the analyst estimate of ($1.62). Revenue for the quarter came in at $45.1 million versus the consensus estimate of $15.61 million.
For earnings history and earnings-related data on Arcturus Therapeutics (ARCT) click here.
... More